BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25421977)

  • 1. Aldosterone antagonists and renal denervation: friends or foes?
    Mahfoud F; Ruilope LM; Böhm M; Schmieder RE
    Hypertension; 2015 Feb; 65(2):280-2. PubMed ID: 25421977
    [No Abstract]   [Full Text] [Related]  

  • 2. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
    Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
    Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Spironolactone versus sympathetic renal denervation to treat true resistant hypertension: results from the DENERVHTA study - a randomized controlled trial.
    Oliveras A; Armario P; Clarà A; Sans-Atxer L; Vázquez S; Pascual J; De la Sierra A
    J Hypertens; 2016 Sep; 34(9):1863-71. PubMed ID: 27327441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal sympathetic denervation in a previously stented renal artery.
    Berra E; Rabbia F; Rossato D; Covella M; Totaro S; Chiara F; Di Monaco S; Veglio F
    J Clin Hypertens (Greenwich); 2014 Mar; 16(3):238-9. PubMed ID: 24387740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Resistant hypertension: from prevention to renal denervation].
    Ruilope LM; Arribas F
    Med Clin (Barc); 2013 Jul; 141(1):27-8. PubMed ID: 23337447
    [No Abstract]   [Full Text] [Related]  

  • 6. Catheter-based renal sympathetic denervation: a targeted approach to resistant hypertension.
    Gewirtz JR; Bisognano JD
    Cardiol J; 2011; 18(1):97-102. PubMed ID: 21305496
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistant hypertension: Renal denervation or intensified medical treatment?
    Morganti A; Mancia G
    Eur J Intern Med; 2018 Apr; 50():6-11. PubMed ID: 29287767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Profound sustained hypotension following renal denervation: a dramatic success?
    Sridhar GS; Watson T; Han CK; Ahmad WA
    Arq Bras Cardiol; 2015 Aug; 105(2):202-4. PubMed ID: 26352181
    [No Abstract]   [Full Text] [Related]  

  • 9. Renal denervation in the treatment of drug-resistant hypertension: current knowledge and future perspectives.
    Prochnau D; Figulla HR; Surber R
    Expert Rev Med Devices; 2013 Mar; 10(2):247-56. PubMed ID: 23480093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal denervation - a novel therapeutic option for resistant hypertension?].
    Ritter A; Sudano Noll I; Suter PM
    Praxis (Bern 1994); 2014 Oct; 103(20):1169-78. PubMed ID: 25270745
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal Denervation for the Treatment of Hypertension: Making a New Start, Getting It Right.
    Weber MA; Kirtane A; Mauri L; Townsend RR; Kandzari DE; Leon MB
    Clin Cardiol; 2015 Aug; 38(8):447-54. PubMed ID: 26216107
    [No Abstract]   [Full Text] [Related]  

  • 12. Editorial: renal sympathetic denervation: a true lack of efficacy, or the victim of a "perfect storm"?
    Baker NC; Waksman R
    Cardiovasc Revasc Med; 2014 Mar; 15(2):61-2. PubMed ID: 24684755
    [No Abstract]   [Full Text] [Related]  

  • 13. Catheter-based renal denervation for treatment of hypertension.
    Azizi M
    Lancet; 2017 Nov; 390(10108):2124-2126. PubMed ID: 28859945
    [No Abstract]   [Full Text] [Related]  

  • 14. Renal denervation in comparison with intensified pharmacotherapy in true resistant hypertension: 2-year outcomes of randomized PRAGUE-15 study.
    Rosa J; Widimský P; Waldauf P; Zelinka T; Petrák O; Táborský M; Branny M; Toušek P; Čurila K; Lambert L; Bednář F; Holaj R; Štrauch B; Václavík J; Kociánová E; Nykl I; Jiravský O; Rappová G; Indra T; Krátká Z; Widimský J
    J Hypertens; 2017 May; 35(5):1093-1099. PubMed ID: 28118281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renal denervation a new treatment option in resistant arterial hypertension].
    Himmel F; Bode F; Schunkert H; Weil J
    Praxis (Bern 1994); 2011 Nov; 100(22):1353-60. PubMed ID: 22048911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expert consensus: renal denervation for the treatment of arterial hypertension.
    Pathak A; Girerd X; Azizi M; Benamer H; Halimi JM; Lantelme P; Lefèvre T; Sapoval M; ; ; ;
    Arch Cardiovasc Dis; 2012; 105(6-7):386-93. PubMed ID: 22977923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transradial renal denervation for the treatment of resistant hypertension.
    Dong H; Jiang X; Liang T; Zou Y; Guan T; Peng M; Song L; Zhang H; Wu H; Xu B; Yang Y; Gao R
    J Invasive Cardiol; 2014 Jul; 26(7):322-7. PubMed ID: 24993989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current technologies: an introduction.
    Daemen J
    EuroIntervention; 2013 May; 9 Suppl R():R75-82. PubMed ID: 23732160
    [No Abstract]   [Full Text] [Related]  

  • 19. Challenging anatomy, how to treat or not to treat?
    Zeller T; Rastan A; Macharzina R; Noory E
    EuroIntervention; 2013 May; 9 Suppl R():R67-74. PubMed ID: 23732158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New drugs, procedures, and devices for hypertension.
    Laurent S; Schlaich M; Esler M
    Lancet; 2012 Aug; 380(9841):591-600. PubMed ID: 22883508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.